Eversept Partners as of March 31, 2020
Portfolio Holdings for Eversept Partners
Eversept Partners holds 58 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Zogenix Com New | 12.4 | $50M | 2.0M | 24.73 | |
Danaher Corporation (DHR) | 8.1 | $32M | 234k | 138.57 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 7.7 | $31M | 276k | 112.61 | |
Tg Therapeutics (TGTX) | 6.0 | $24M | 2.5M | 9.84 | |
Apellis Pharmaceuticals (APLS) | 6.0 | $24M | 900k | 26.79 | |
Chemocentryx | 5.8 | $23M | 580k | 40.18 | |
Glaxosmithkline Sponsored Adr | 4.9 | $20M | 511k | 38.89 | |
Amarin Corp Spons Adr New (AMRN) | 4.7 | $19M | 4.7M | 4.00 | |
Deciphera Pharmaceuticals | 4.2 | $17M | 414k | 41.17 | |
Astrazeneca Sponsored Adr (AZN) | 3.9 | $16M | 353k | 44.66 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 3.8 | $16M | 60k | 257.75 | |
BioCryst Pharmaceuticals (BCRX) | 3.8 | $15M | 7.5M | 2.00 | |
Ensign (ENSG) | 3.3 | $13M | 357k | 37.66 | |
Hca Holdings (HCA) | 2.3 | $9.1M | 101k | 89.85 | |
Model N (MODN) | 2.1 | $8.3M | 374k | 22.21 | |
Sanofi Sponsored Adr (SNY) | 2.1 | $8.3M | 190k | 43.72 | |
Fate Therapeutics (FATE) | 1.7 | $6.8M | 306k | 22.21 | |
Dex (DXCM) | 1.3 | $5.3M | 20k | 269.27 | |
Taro Pharmaceutical Inds SHS (TARO) | 1.2 | $4.7M | 77k | 61.20 | |
Kadmon Hldgs | 1.0 | $4.1M | 975k | 4.19 | |
Pennant Group (PNTG) | 1.0 | $4.0M | 282k | 14.16 | |
Momenta Pharmaceuticals | 1.0 | $4.0M | 147k | 27.20 | |
Radius Health Com New | 1.0 | $3.9M | 301k | 13.00 | |
Acceleron Pharma | 0.9 | $3.8M | 42k | 89.87 | |
Biohaven Pharmaceutical Holding | 0.9 | $3.6M | 106k | 34.03 | |
Iovance Biotherapeutics (IOVA) | 0.7 | $2.7M | 90k | 29.93 | |
GenMark Diagnostics | 0.5 | $2.2M | 524k | 4.12 | |
Cytokinetics Com New (CYTK) | 0.5 | $2.1M | 182k | 11.79 | |
Community Health Systems (CYH) | 0.5 | $1.9M | 580k | 3.34 | |
Align Technology Put Option (ALGN) | 0.4 | $1.7M | 10k | 173.95 | |
Envista Hldgs Corp (NVST) | 0.4 | $1.6M | 109k | 14.94 | |
Oxford Immunotec Global Ord Shs | 0.4 | $1.6M | 172k | 9.26 | |
Agile Therapeutics | 0.3 | $1.3M | 712k | 1.86 | |
Myokardia | 0.3 | $1.3M | 28k | 46.88 | |
Albireo Pharma | 0.3 | $1.3M | 78k | 16.37 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $1.3M | 210k | 5.99 | |
Immunovant (IMVT) | 0.3 | $1.2M | 77k | 15.56 | |
Liquidia Technologies (LQDA) | 0.3 | $1.2M | 245k | 4.71 | |
Heska Corp Com Restrc New | 0.3 | $1.1M | 21k | 55.30 | |
Otonomy | 0.3 | $1.1M | 562k | 1.97 | |
Dicerna Pharmaceuticals | 0.3 | $1.1M | 60k | 18.37 | |
Teligent | 0.3 | $1.1M | 3.9M | 0.28 | |
Scpharmaceuticals (SCPH) | 0.2 | $980k | 132k | 7.40 | |
Cyclerion Therapeutics | 0.2 | $893k | 337k | 2.65 | |
Affimed Therapeutics B V | 0.2 | $886k | 561k | 1.58 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $812k | 72k | 11.34 | |
Artara Therapeutics | 0.2 | $747k | 33k | 23.00 | |
Inflarx Nv (IFRX) | 0.2 | $747k | 196k | 3.82 | |
Sesen Bio | 0.2 | $729k | 1.3M | 0.56 | |
Aquestive Therapeutics (AQST) | 0.2 | $657k | 300k | 2.19 | |
Igm Biosciences (IGMS) | 0.1 | $549k | 9.8k | 56.15 | |
Macrogenics (MGNX) | 0.1 | $535k | 92k | 5.82 | |
Puma Biotechnology (PBYI) | 0.1 | $492k | 58k | 8.44 | |
Eiger Biopharmaceuticals | 0.1 | $474k | 70k | 6.80 | |
BioDelivery Sciences International | 0.1 | $465k | 123k | 3.79 | |
eHealth (EHTH) | 0.1 | $444k | 3.2k | 140.82 | |
Air Lease Corp Cl A Put Option (AL) | 0.1 | $443k | 20k | 22.14 | |
Pfenex | 0.1 | $408k | 46k | 8.82 |